The purpose of this study was to report the clinical features, laboratory findings, and cytomorphology, and prognosis of three patients with myelomatous pleural effusion (MPE). The literature pertaining to MPE was reviewed. The three cases and literature review suggest that MPE is rare and often associated with a poor prognosis. The correct diagnosis depends on the aggressive clinical characteristics, laboratory findings, and chromosomal abnormalities, but routine pathological examination of the pleural effusion has low sensitivity. Cell blocks stained with hematoxylin & eosin and by immunohistochemistry revealed that abnormal proliferation of plasma cells and light chain restrictive expression in MPE may be helpful for improving the detection rate of MPE. 
Cell block of PE with hematoxylin and eosin (HE) staining and immunohistochemistry showed that PC had very prominent, centrally located (immunoblast-like) nucleoli ( Figure 1D ) and were positive for CD138, CD38, and lambda light chains ( Figure 1E,F 
| Case 2
A 57-year-old female patient reported with a two-month history of dull right lower chest pain that was not made worse by coughing or deep inspiration. The patient had been on a trial antibiotic treatment, which did not alleviate her symptoms. Therefore, she was diagnosed with 
| D ISC USSION
MM is a clonal B-cell malignancy, characterized by proliferation of plasma cells and secretion of paraproteins. These plasma cells accumulate predominantly in the bone marrow; rarely, they invade other areas, especially the thorax. Pleural effusions are rarely associated with MM and most often signify a concurrent disease process. MPE are even more unusual, they occur in <1% of the cases, and carry a poor prognosis. 3, 6 The first case of pleural effusion and involvement of serous cavities in MM was reported in 1994 by Rodriguez et al. 7 Nevertheless, the incidence of PME could be higher than that reported by Kintzer et al. 6, 8 and could depend on the method of detection. Indeed, modern methods such as flow cytometry could allow for the determination of the clonal nature of the disease. 
| 607
Oudart et al. 12 summarized the six etiologic factors that lead to pleural effusion in MM: congestive heart failure secondary to amyloidosis; chronic renal failure; nephritic syndrome secondary to renal tubular infiltration with paraprotein and development of glomerular damage; direct infiltration of pleural fluid from adjacent tissues; hypoalbuminemia; pulmonary embolism, secondary neoplasm, lymphatic drainage obstruction by tumor infiltration, infection and pleural myelomatous involvement. Here, myelomatous involvement of pleural and adjacent tissues were the most common reason for pleural exudates in our series.
A diagnostic criterion for MPE was suggested in 1994 by Rodriguez et al. 7 Three parameters are defined to confirm MPE: (1) demonstration of a monoclonal protein in pleural fluid electrophoresis; (2) detection of atypical plasma cells in the pleural fluid; and (3) histological confirmation with a pleural biopsy or by autopsy.
Generally, the most common isotype in myeloma is IgG (50%), followed by IgA (20%), light chain (20%), and IgD, IgE, IgM, and biclonal (<10%). 13 Some MPE case reports have been published. [14] [15] [16] [17] [18] A study of 23 patients with MM and PE by Zhong et al. 19 represents the largest case series to date. In their study, 80% of PE cases were IgA subtype, whereas most of the remaining cases were classified as the IgG subtype. 20 More cases of PE in the left side of the chest have been reported. 21 Among our three cases, two presented with IgG type MM and the other was IgD. One important feature was that the two cases had bilateral pleural effusion. Due to plasma cell infiltration into the pleura. 22 Cytological identification of malignant plasma cells within the pleural effusion has been considered as the best diagnostic method for MPE, 23 especially for those patients who present with pleural effusion as one of the first signs. Sometimes, their routine blood and fluid biochemistry tests are nonspecific. In these cases, it is hard for a respiratory physician to take hematological malignancy into consideration and traumatic investigation is needed to give a final diagnosis. Due to the limited number of malignant plasma cells and their potential in vitro degeneration, diagnosis may fail in patients undergoing pleural effusion puncture examination. 8 In our cases, case#2 had been misdiagnosed at their local clinic. We found diagnosis was assisted by taking advantage of the paraffin embedded cell block technique after centrifugation of the pleural effusion. The pathological sections easily revealed abnormal proliferation of plasmocytes and immunophenotyping. Therefore, cell blocks should be considered to assist with the diagnosis and differential diagnosis of serous cavity effusion. Compared to pleural biopsy, pleural effusion cell block is simpler and accurate, with less pain to the patient.
Pleural biopsies are not always done in these patients and when done they are not always diagnostic or even helpful. 24, 25 Morphology of plasma cells can be divided into three categories, mainly based on changes to the nucleus, such as diffuse chromatin pattern, prominent nucleolus, irregular contour of the nuclear membrane, and/or nuclear size larger than expected. These criteria correspond to "immaturity" or "aggressiveness" of the PC clone in MM. 26 In about half of the cases (40%-50% patients) with the so-called "mature" PC subtype, N/C ratio asynchrony is observed, i.e., presence of one nucleolus, finely dispersed chromatin, and/or irregular nuclear contour contrast with a still large and blue (mature) cytoplasm. PC display condensed chromatin and the nucleolus is either absent or inconspicuous or <1 mm in size, as in normal PC.
One subtype is related to a low amount of cytoplasm, defined as lymphoplasmacytoid myeloma (10%-15% patients) 27 or as small cell type. 28 If nearly all PC from this subtype display mature chromatin, at least 25%-30% show high N/C ratio, usually >0. 31 They are considered as the most immature PC.
32
Mature myeloma is related to favorable outcome, while immature myeloma, particularly plasmablastic myeloma, is related to dismal prognosis. Nevertheless, such classification is no longer included in current prognostic schemes. 33 Among our three cases, two were of the lymphoplasmacytoid type and one was of the plasmablasts type. There was no mature PC.
The overall median survival for MPE has been reported as 4 months (ranging from 3 to 50 months), which is much lower than the median survival of 29 months observed in stage III MM. 34 Among our patients, one died 5 months after diagnosis of MPE, one died after 7 months, and one was in a coma (the relatives asked for discharge and she was lost to follow-up). All cases were stage III. The reason why these MPE patients showed short survival is relatively clear. At diagnosis, most patients were classified with advanced clinical stages using the ISS system. At the time of development of MPE, their laboratory characteristics already indicated an aggressive clinical course.
| CON CL U S I ON
The present report and literature review suggest that MPE is rare and often associated with a poor prognosis. The correct diagnosis depends on the aggressive clinical characteristics, laboratory findings, and chromosomal abnormalities, but routine pathological examination of PE has low sensitivity. Cell blocks stained with HE and by immunohistochemistry revealed that abnormal proliferation of PC and light chain restrictive expression in MPE may be useful for improving the detection rate of MPE.
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